Login to Your Account



Other News To Note


Friday, November 9, 2012

• The Grünenthal Group, of Aachen, Germany, and Amura Therapeutics Ltd., of Cambridge, UK, signed a collaboration agreement to develop cathepsin inhibitors in pain and inflammation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription